Should we be using 5-HT3 antagonists as first line antiemetic therapy in cisplatin-based chemotherapy?
作者信息
Mansi J L, Evans T R, Smith A, Oakley C, Wastnage R, Dalgleish A
出版信息
Ann Oncol. 1993 May;4(5):433-5. doi: 10.1093/oxfordjournals.annonc.a058531.
Abstract
摘要
Zotero 插件